Peer Review History

Original SubmissionNovember 2, 2021
Decision Letter - Ilya Ioshikhes, Editor, Eli Zunder, Editor

Dear Professor Lin,

Thank you very much for submitting your manuscript "HiCImpute: A Bayesian Hierarchical Model for Identifying Structural Zeros and Enhancing Single Cell Hi-C Data" for consideration at PLOS Computational Biology.

As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

We have now received detailed reports on your manuscript from 2 referees. You will see from their comments below that, while they find your work of interest, several important points remain that need to be addressed. We would like to consider your response to these concerns in the form of a revised manuscript before we make a final decision on publication.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Eli Zunder

Guest Editor

PLOS Computational Biology

Ilya Ioshikhes

Deputy Editor

PLOS Computational Biology

***********************

We have now received detailed reports on your manuscript from 2 referees. You will see from their comments below that, while they find your work of interest, several important points remain that need to be addressed. We would like to consider your response to these concerns in the form of a revised manuscript before we make a final decision on publication.

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: Comments to the Author

Xie et al. develop a Bayesian hierarchy model, HiCImpute, to improve single cell Hi-C (scHi-C) data and identify structural and sampling zeros, which focus on addressing an important problem in scHi-C analysis. The article is in general well-written and easy to read. My main concern lies in the insufficient description of HiCImpute. My suggestion is therefore to supplement related content to ensure a clearer description of this model.

Below, I outline my suggestions:

Major suggestions:

1) What is Bayesian Hierarchical Model and why it could be applied to improve scHi-C data and identify structural zeros and sampling zeros. Above question should be described in the introduction.

2) Whether HiCImpute can enhance scHi-C data based on the identification of structural zeros and sampling zeros, that is, whether HiCImpute can only enhance the structural zeros but not sampling zeros.

3) The bulk data used in HiCImpute is combining from single cells? Whether it can apply real bulk Hi-C data and is it necessary to use it. Besides, whether HiCImpute would introduce noise using bulk data as reference to improve Hi-C data. In other words, whether HiCImpute would enhance the signal which exist in bulk data but not in some single cell? In this situation, the heterogeneity of 3D structure may be neglected or incorrectly estimated.

4) Whether HiCImpute could be applied to sample with large numbers of cells? What about the accuracy of improvement and time consumption?

5) Whether the better performance of HiCImpute is related to the simulation procedure carried out in the text?

Minor suggestions:

1) P5: Taking on the challenging problems of separating the zeros into structural zeros and sampling zeros. What’s the challenging problems specifically refers to? And why could Bayesian Hierarchical Model can address these problems?

2) It’s better to adjust Figure 1 to show the schematic of the HiCImpute algorithm more clearly.

3) How to validate the cluster results are more accurate after data improved in Table2, especially in GM and K562 cell line, which are difficult to explain the biological meaning of cluster results? Number of clusters is not a sufficient criterion for judging the accuracy of classification.

4) There are a few format problems here and there. Besides, the abbreviations used in the text should be checked carefully, some words (e.g. structural zeros) are abbreviated repeatedly and the full name of these words appear after abbreviated.

P7L17: ...consider.It.. There should be a space between ‘.’ and It.

P16L17: Among those observed 0’s, some are true 0s (i.e. structural zeros, SZs) ..., irregular description.

5) It’s better to unify the use of proper nouns (e.g. sampling zeros and dropouts) to avoid confusing readers.

6) Please confirm the format requirement of the reference. The style of reference is not consistent with the article published recently.

Reviewer #2: Xie et al. propose a method named HiCImpute to impute zeros in single-cell HiC data, while trying to differentiate between structural zeros and sampling zeros. The authors claim that HiCImpute outperforms three existing methods based on a set of simulated and real data studies. I agree this is an important research topic, but additional analyses or clarifications are in need to improve the validity of the method and strength of the claim. Below are my detailed comments.

The sequencing depth of the best K562 scHi-C data is 300,000. Why did the authors only consider sequencing depths of 2K, 4K, and 7K in the simulation? Can the authors show results on data with larger sequencing depths?

The simulated contact matrix is 61 by 61. How is this dimension selected? This is quite small compared with the actual contact matrices.

What’s the difference between data of T1, T2, and T3? The Method section mentions they are mimicking three K562 cells, but there are essentially the same cell type. It would be more interesting to evaluate the methods using simulated data of different cell types, to test the methods’ performance given different data structures.

From the simulated data, the sparsity levels of the observed data and expected data are very similar (Figure 2). Based on the authors’ description of single cell HiC data in Introduction, the observed data is supposed to be much sparser than expected data.

“For the three comparison methods, an observed zero is identified as SZ if its imputed value is less than 0.5.” Is this threshold applied to count data or normalized data? If normalized data is used, how is the normalization done?

Can the authors clarify if HiCImpute is the only method that requires bulk data among the four compared methods? This is not very clear in the current manuscript.

It seems that the proposed Bayesian hierarchy model requires prior information of cell types or clusters, since the model assumes that the K cells have the same pattern of SZs. Therefore, it is not clear how HiCImpute is used to improve clustering analysis in the real data applications. Was HiCImpute applied to single cell data without using any cell type information? How does the model distinguish different cell types during the imputation process?

For the mean of the Gamma distribution, how is the neighborhood defined? Is this done in a data-adaptive manner? Does this range affect the imputation performance?

Can the authors explain why this mean is defined based on the ratio between bulk and single-cell data?

Does the posterior distribution have a closed-form representation? If yes, this should be added to the main text. It would also be helpful to list the full model (in math notations) after explaining individual model assumptions in Method.

**********

Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: None

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Xiaochen Bo

Reviewer #2: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example in PLOS Biology see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Revision 1

Attachments
Attachment
Submitted filename: Response to Reviewers.pdf
Decision Letter - Ilya Ioshikhes, Editor, Eli Zunder, Editor

Dear Professor Lin,

We are pleased to inform you that your manuscript 'HiCImpute: A Bayesian Hierarchical Model for Identifying Structural Zeros and Enhancing Single Cell Hi-C Data' has been provisionally accepted for publication in PLOS Computational Biology.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology. 

Best regards,

Eli Zunder

Guest Editor

PLOS Computational Biology

Ilya Ioshikhes

Deputy Editor

PLOS Computational Biology

***********************************************************

Dear Dr. Lin and co-authors,

Thank you very much for submitting your revised manuscript files. I think it looks great, and our two reviewers both commented that all their concerns were addressed. I am pleased to inform you that I'm recommending your manuscript, "HiCImpute: A Bayesian Hierarchical Model for Identifying Structural Zeros and Enhancing Single Cell Hi-C Data" be accepted for publication in PLOS Computational Biology.

All the best,

Eli Zunder

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The authors have addressed all my previous concerns. I suggest to accept this article.

Reviewer #2: The revised manuscript has addressed all my questions.

**********

Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: None

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Formally Accepted
Acceptance Letter - Ilya Ioshikhes, Editor, Eli Zunder, Editor

PCOMPBIOL-D-21-01981R1

HiCImpute: A Bayesian Hierarchical Model for Identifying Structural Zeros and Enhancing Single Cell Hi-C Data

Dear Dr Lin,

I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Andrea Szabo

PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom ploscompbiol@plos.org | Phone +44 (0) 1223-442824 | ploscompbiol.org | @PLOSCompBiol

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .